Fiscal Year End Company Status Exempt Flag February 29 Trading N Incorporation Locations Inc. Date Expiry Date Country Region Description 3/May/2018    Canada  Ontario    Exchange Filing Office Location Toronto Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Research and Development in the Physical, Engineering and Life Sciences  (not available)  Securities Symbol Security Name Market Status TTI Thiogenesis Therapeutics, Corp. TSX Venture TRADING Name History From To Thiogenesis Therapeutics, Corp. 13/Apr/2022 Present Company Facts Reconciliation Subject Date Returned (not available) Associations Auditing Firm:  MNP LLP Transfer Agent:  TSX Trust Company
Latest Information Type Date Title             Bulletins  8/Jun/2026  PP-N-B Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data